Background: The project abstract outlines the significant genetic diversity and structural variability exhibited by Fowl Adenovirus (FAdV) isolates. 100 liver samples from suspected Adenovirus-infected bird samples underwent virus isolation through homogenization and filtration.
Materials and Methods: Polymerase Chain Reaction (PCR) was utilized to amplify a specific segment of the viral DNA, which was then sequenced and analyzed for phylogenetic relationships. The physicochemical properties of the proteins from FAdV serotypes 4, 8, and 11 were analyzed, along with structural modelling.
Results: DHEA was identified as a suitable ligand for molecular docking, and docking studies were performed to explore interactions between the ligand and the viral proteins. ADMET analysis was conducted to assess potential drug-like properties and toxicity of the compounds. Ultimately, effective inhibitors were identified based on docking scores and molecular properties, highlighting potential avenues for therapeutic development against fowl adenoviruses.
Conclusion: This diversity is crucial in the development of vaccines and the design of antiviral drugs. Identifying potential drug targets and variations in ligand binding affinities underscores the importance of considering genetic diversity when devising immunophylactic and therapeutic strategies. The abstract emphasizes the need for future research to leverage these findings to deepen our comprehension of FAdV genetic diversity and enhance disease control measures by developing potent and effective homologous vaccines.
Keywords: Fowl adeno virus, Hexon Protein Structure, Molecular Docking, Phylogenetic analysis.
